Tag: intrathecal drug delivery

Philip Kim Tim Deer

Decision-making in intrathecal drug delivery devices “life-threatening” amid COVID-19

Amid the COVID-19 pandemic, the need to prevent the spread of disease and manage critical hospital resources has never been more critical. In a...

Latest FDA caution for the use of off-label drugs in intrathecal...

While the US Food and Drug Administration (FDA) has called for caution regarding the use of off-label medications administered intrathecally, pain management experts have...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

FDA approves new clinician programmer for SynchroMed II intrathecal drug delivery...

The US Food and Drug Administration (FDA) has approved a new clinician programmer for use with the SynchroMed II Intrathecal Drug Delivery system (Medtronic),...